Home/Stocks/Financials

JPMorgan American Investment Trust PLC

JAM.L·Financials·Market Cap £2.0b
Rank #17 of 280
Quantitative Model · 280 Stocks Analysed
£12.50
+11.41% YTD
52W: £10.41 - £12.58

Factor Analysis Summary

Editorial assessment generated from JPMorgan American Investment Trust PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, JPMorgan American Investment Trust PLC (JAM.L) currently holds an overall rank of #17 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation; profitability (ROE 4.1%, net margin 96.2%), where it demonstrates strong profitability metrics, ranking in the top quartile for earnings quality and return on capital; and solvency (debt/equity 0.1), where it demonstrates a robust solvency position with conservative leverage and strong balance sheet coverage.

Areas requiring attention include liquidity, where liquidity is middling and may not suit investors requiring large block execution, as well as asset efficiency, where asset efficiency is average and does not contribute meaningfully to the composite score.

Within the Financials sector, JPMorgan American Investment Trust PLC sits at composite rank #17, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

With a composite rank in the top decile (better than 94% of the universe) and 4 factors in the top quartile, JPMorgan American Investment Trust PLC presents a broadly attractive multi-factor profile, led by market trading and tempered only by liquidity.

Strongest Factors

  • Market Trading — Rank 23/280 (top quartile)
  • Profitability — Rank 36/280 (top quartile)
  • Solvency — Rank 44/280 (top quartile)

Weakest Factors

  • Liquidity — Rank 168/280 (middle of the pack)
  • Asset Efficiency — Rank 148/280 (middle of the pack)

Score Analysis

JPMorgan American Investment Trust PLC is ranked #17 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

81/280
Average Score
Liquidity
Fair168/280
Valuation
Good97/280
Profitability
Excellent36/280
Solvency
Excellent44/280
Asset Efficiency
Fair148/280
Mkt Trading
Excellent23/280
Technical
Excellent53/280

1. Liquidity

Score: 168/280

How liquid is JAM and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current Ratio5.63x
Range: N/ARank 27/280
–
TTM Operating Cash Flow0.62x
Range: N/ARank 86/280
–
Liquidity Coverage RatioN/A
Range: 100-150
–
Intangible Asset RatioN/A
Range: 10 - 30Rank 193/280
–
Cash-to-Debt Ratio0.12x
Range: N/ARank 189/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
5.63x
Sector: N/A

Overall Liquidity Rank

Rank within universe#168/280
Best (1)Worst (280)

2. Valuation

Score: 97/280

Is JAM undervalued compared to its peers and fair value metrics?

2/7
valuation criteria met
–
FY27e P/EN/A
Range: 8x - 18x
–
FY26e P/EN/A
Range: 8x - 18x
–
FY27e Net Div Yld (%)N/A
Range: 3.0 - 8.0
✗
Div Payout Ratio5.06%
Range: 30 - 55Rank 50/280
–
Current EV/EBITDA22.5x
Range: N/ARank 255/280
✓
Current P/TBV0.98x
Range: 0.8x - 2.0xRank 78/280
✓
Current P/B0.98x
Range: 0.8x - 2.0xRank 91/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
5.6x
FY26e P/E
Forward estimate
N/A
FY27e P/E
Forward estimate
N/A
Current P/B
Price-to-Book
0.98x
Current P/TBV
Tangible Book Value
0.98x
Current EV/EBITDA
Enterprise Value
22.5x
FY26e EV/EBITDA
Forward estimate
N/A
FY27e EV/EBITDA
Forward estimate
N/A

Dividend

JAM pays a dividend yield of 0.94%.

Current Yield
0.94%
FY27e Net Div Yield
N/A
FY26e Gross DPS
N/A
FY27e Gross DPS
N/A

3. Profitability

Score: 36/280

How profitable is JAM relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin96.2%
Range: 15 - 30Rank 18/280
–
T12 FCF Margin0.1%
Range: N/ARank 180/280
–
FY27e RoEN/A
Range: 10 - 16
–
FY26 EPS GrowthN/A
Range: 8 - 15
–
FY27e EPS GrowthN/A
Range: 6 - 12
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
96.2%
Current RoCE
4.1%
FY27e RoE
N/A
T12 FCF Margin
0.1%

4. Solvency

Score: 44/280

How strong is JAM's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.05x
Range: 0.5x - 1.5xRank 39/280
–
Interest Coverage RatioRank 75
Range: N/ARank 75/280
–
Net Leverage RatioN/A
Range: N/A
–
Altman Z-Score (Manufacturing)21.85
Range: N/ARank 39/280
–
Z-Score (Non Manufacturing)Rank 36
Range: N/ARank 36/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
0.05x
Net Leverage Ratio
N/A
Interest Coverage
Rank 75
T12 FCF Margin
0.1%

Altman Z-Score

21.85
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 148/280

How efficiently does JAM deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.19x
Range: N/ARank 188/280
–
TTM CAPEX/SalesN/A
Range: 1 - 3
–
Working Capital Turnover182.05x
Range: N/ARank 3/280
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#148/280
Best (1)Worst (280)

6. Market Trading

Score: 23/280

How liquid and actively traded is JAM?

1/2
market trading criteria met
–
Intraday Sentiment (%)N/A
Range: 40 - 75
–
10D-Avg v/s 3M-Avg Vol227%
Range: N/ARank 50/280
✓
Avg Directional Index 30D17.9
Range: 012 - 45Rank 165/280
–
Parabolic SAR1258.00
Range: N/ARank 75/280
–
Stock Rating RankN/A
Range: N/A
Market Cap
£2,031,909,163
Enterprise Value
£2,151,511,163

Trading Volume

7. Technical

Score: 53/280

What do the technical indicators say about JAM?

0/5
technical criteria met
–
CMP v/s 52-WH-0.6%
£12.58£10.41
-0.6%CMP: £12.50
Range: N/ARank 9/280
–
CMP v/s 52-WL20.1%
£12.58£10.41
+20.1%CMP: £12.50
Range: N/ARank 111/280
–
RSI 14D62.2
062.2 - Bullish100
Range: N/ARank 50/280
–
MA50 - MA200Bullish
£11.73+0.53£12.26
Range: N/ARank 79/280
–
MACD Rank2.16
Golden Cross
MACD: 2.16
Range: N/ARank 100/280

RSI (14 Day)

62.2
Bullish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£12.26
200 SMA£11.73
SignalGolden Cross (Bullish)
MACD2.16

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does JAM compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
JAM#171689736442353
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for JPMorgan American Investment Trust PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.